BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2005
View Archived Issues
European CE Mark for AlzheimAlert test kit
Read More
Phase I program begins for HCV-796
Read More
4SC and Sanwa Kagaku Kenkyusho establish drug development collaboration
Read More
REN-850 enters phase Ia study for MS
Read More
Phase III Insegia study fails to meet primary endpoint
Read More
Private financing will fund Jerini's icatibant development
Read More
Vertex licenses VX-944 to Avalon for cancer
Read More
Enrollment targets met in two phase II studies of squalamine for AMD
Read More
Successful launch for Familion test
Read More
CTI-01 enters phase II study
Read More
Orphan drug designation for INO-1001
Read More
Seattle Genetics and CuraGen expand antibody-drug conjugate collaboration
Read More
Adherex updates program progress
Read More
Positive phase II interim results for talabostat in metastatic melanoma
Read More
NIH funding for development of protease inhibitors for orthopoxvirus infections
Read More
African program begins for Calypte's Aware rapid HIV-1/2 test platform
Read More
NV-1020 reported safe in patients with hepatic colorectal metastases
Read More
Promising effects reported for 131I-labetuzumab in colorectal cancer patients with liver metastases
Read More
Good safety profile found for E-7070 plus irinotecan in cancer patients
Read More
Update on the antitumor effects of NPI-0052 in colorectal cancer
Read More
Antitumor efficacy of temsirolimus in neuroendocrine carcinomas
Read More
Pfizer claims new cannabinoid CB1 receptor antagonists for obesity
Read More
Novel PPAR ligands jointly disclosed by Fujisawa and Daicel
Read More
New serotonin 5-HT1B receptor antagonists identified at Pfizer
Read More
Six series of phosphatidylinositol 3-kinase inhibitors and their use reported by Pfizer
Read More
Phase I study of NMI-861, a combined yohimbine/L-arginine treatment for male erectile dysfunction
Read More
Effects of FK-419, a GPIIb/IIIa antagonist, in a model of ischemic brain injury
Read More
Cytotoxic activity of HMN-176 in an array of human tumor specimens
Read More